-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
LAVA Therapeutics NV quarterly and annual Income Tax Expense (Benefit) history and change rate from 2023 to Q3 2025.
- LAVA Therapeutics NV Income Tax Expense (Benefit) for the quarter ending 30 Sep 2025 was $6,000, a 93.8% decline year-over-year.
- LAVA Therapeutics NV Income Tax Expense (Benefit) for the twelve months ending 30 Sep 2025 was $682,000.
- LAVA Therapeutics NV annual Income Tax Expense (Benefit) for 2024 was $630,000, a 145% increase from 2023.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)